# EMPAGLIFLOZIN
> **ANDA212371** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LIMITED · Approved 2026-05-21
## Drug
- **FDA Application Number:** ANDA212371
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMPAGLIFLOZIN
- **Generic name:** Empagliflozin
- **Active ingredients:** EMPAGLIFLOZIN
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AUROBINDO PHARMA LIMITED
- **First approval:** 2026-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212371)
---
*MORVS · CC0 1.0*